Shingles Vaccination Programme GP toolkit for improving uptake, August 2023 (england.nhs.uk). Available at: https://www.england.nhs.uk/london/wp-content/uploads/sites/8/2023/10/Shingles-GP-toolkit-3.pdf. Accessed July 2024 NHS England. Quality and outcomes framework guidance for 2023/2024, ve...
effective and well-tolerated vaccine option for HZ and PHN in adults aged ≥ 50 years. RZV is not contraindicated in immunocompromised individuals, and is preferred over a live attenuated HZ vaccine in immunocompetent individuals, according to the US and Canadian guidelines. During the peer re...
Vaccination with SHINGRIX may not protect all individuals. Ask your healthcare provider about the risks and benefits of SHINGRIX. Only a healthcare provider can decide if SHINGRIX is right for you. SHINGRIX is not indicated for the prevention of chickenpox. Inside information Th...
However, for adults 18 years and older who are immunodeficient, immunosuppressed or likely to become immunosuppressed due to known disease or therapy and who would benefit from a shorter vaccination schedule, the second dose can be...
For immunocompetent adults, Shingrix is intended to be administered in two doses, 2 to 6 months apart. However, for adults who are or will be immunodeficient or immunosuppressed due to known disease or therapy and who would benefit from a shorter vaccination schedule, the second dose can be...